News For VICL From The Last 14 Days Check below for free stories on VICL the last two weeks.
There are 3 items on the Fly with pertinent information.
Sign up for a free trial to see the rest of the stories you've been missing. |
|
February 10, 2012
|
| 11:58 EDT |  | VICL |
|
|
February 8, 2012
|
| 06:43 EDT |  | VICL |
| theflyonthewall.com: | Vical reports Q4 EPS (9c) vs. consensus (12c) | | Reports revenue $1.93M vs. consensus $2.04M :theflyonthewall.com |
|
|
January 30, 2012
|
| 06:43 EDT |  | VICL |
| theflyonthewall.com: | Vical presents case study on successful design of Allovectin | | Vical Incorporated announced that the company will present a case study of its Allovectin Phase 3 trial at the Phacilitate Cell & Gene Therapy Forum 2012 (Washington – January 30 - February 1). Alain P. Rolland, Pharm.D., Ph.D., Vical's Executive Vice President of Product Development, is scheduled to present on Monday, January 30...Dr. Rolland's presentation reviews the company's success in designing and conducting its ongoing multinational pivotal Phase 3 melanoma trial through the Special Protocol Assessment process with the U.S. Food and Drug Administration, FDA, and outlines manufacturing and commercialization considerations in support of the possible licensure of Allovectin®. :theflyonthewall.com |
|
|
|
Subscribe for More Information